Literature DB >> 18085655

Enhanced cytotoxicity of saporin by polyamidoamine dendrimer conjugation and photochemical internalization.

Ping-Shan Lai1, Chin-Ling Pai, Cheng-Liang Peng, Ming-Jium Shieh, Kristian Berg, Pei-Jen Lou.   

Abstract

Because of the lack of membrane binding subunit, type I ribosome-inactivating proteins (RIPs) are not very toxic to cells unless action is taken to allow for toxin internalization to the cytosol. To overcome the potential barriers that greatly hinder the cellular uptake and intracellular release of saporin, a type I RIP, we used generation 4 polyamidoamine (PAMAM) dendrimer as the carrier to improve its endocytic uptake, passive tumor targeting, and implemented the photochemical internalization (PCI) technology to facilitate its cytosolic release. Our results showed that the cellular uptake of saporin was increased after conjugation with the PAMAM dendrimer and the cytotoxic effect was improved by more than 1 order of magnitude. The cytotoxicity of free saporin and PAMAM-saporin was further enhanced by the PCI technology. PCI changed the mechanism of cellular uptake of free saporin and then caused more saporin entering into the cells. After the PCI treatment, PAMAM-saporin was not only internalized into the cytosol but also efficiently entered the nuclei. Our results indicated that conjugating to PAMAM dendrimer is a possible approach to enhance the cellular uptake of saporin. PCI is a promising technology to significantly enhance the cytotoxicity of both free saporin and PAMAM-saporin. Combining both polymer conjugation and PCI approaches may improve the efficacy of RIPs in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18085655     DOI: 10.1002/jbm.a.31760

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  9 in total

Review 1.  Nanoparticle-mediated drug delivery for treating melanoma.

Authors:  Vaibhav Mundra; Wei Li; Ram I Mahato
Journal:  Nanomedicine (Lond)       Date:  2015-08-05       Impact factor: 5.307

2.  Insights into the mechanism of cell death induced by saporin delivered into cancer cells by an antibody fusion protein targeting the transferrin receptor 1.

Authors:  Tracy R Daniels-Wells; Gustavo Helguera; José A Rodríguez; Lai Sum Leoh; Michael A Erb; Graciel Diamante; David Casero; Matteo Pellegrini; Otoniel Martínez-Maza; Manuel L Penichet
Journal:  Toxicol In Vitro       Date:  2012-10-17       Impact factor: 3.500

Review 3.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

4.  Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin.

Authors:  Marzena Szwed; Katarzyna D Kania; Zofia Jozwiak
Journal:  Cell Oncol (Dordr)       Date:  2014-11-20       Impact factor: 6.730

Review 5.  Enhancing the efficacy of cytotoxic agents for cancer therapy using photochemical internalisation.

Authors:  Alejandra Martinez de Pinillos Bayona; Caroline M Moore; Marilena Loizidou; Alexander J MacRobert; Josephine H Woodhams
Journal:  Int J Cancer       Date:  2015-03-23       Impact factor: 7.396

Review 6.  Strategies to Improve the Clinical Utility of Saporin-Based Targeted Toxins.

Authors:  Francesco Giansanti; David J Flavell; Francesco Angelucci; Maria Serena Fabbrini; Rodolfo Ippoliti
Journal:  Toxins (Basel)       Date:  2018-02-13       Impact factor: 4.546

7.  Synergistic antitumor activity from two-stage delivery of targeted toxins and endosome-disrupting nanoparticles.

Authors:  Xingfang Su; Nicole Yang; K Dane Wittrup; Darrell J Irvine
Journal:  Biomacromolecules       Date:  2013-03-11       Impact factor: 6.988

Review 8.  Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers.

Authors:  Hendrik Fuchs; Alexander Weng; Roger Gilabert-Oriol
Journal:  Toxins (Basel)       Date:  2016-07-01       Impact factor: 4.546

Review 9.  Plant Ribosome-Inactivating Proteins: Progesses, Challenges and Biotechnological Applications (and a Few Digressions).

Authors:  Maria Serena Fabbrini; Miku Katayama; Ikuhiko Nakase; Riccardo Vago
Journal:  Toxins (Basel)       Date:  2017-10-12       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.